- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT07735884
Comparison of Ultrasound-Guided Fascia Iliaca Compartment Block Versus Intravenous Tramadol for Positioning of Femur Fracture Patients Before Spinal Anaesthesia
This randomized clinical study compared two methods of pain relief used before spinal anaesthesia in patients undergoing surgery for a femur fracture. Positioning a patient with a fractured femur into the side-lying position required for spinal anaesthesia can cause severe pain because movement may disturb the fractured bone.
A total of 64 patients aged 18 to 60 years were included and were assigned to one of two treatment groups. One group received intravenous tramadol, while the other group received an ultrasound-guided fascia iliaca compartment block, in which local anaesthetic was injected near the nerves supplying the hip and upper thigh. Pain was measured using a visual analogue scale when the patient arrived on the operating table and again during positioning in the lateral decubitus position before spinal anaesthesia.
The study was conducted to determine which treatment provided better pain relief and made positioning for spinal anaesthesia more comfortable. It was hypothesized that the ultrasound-guided fascia iliaca compartment block would reduce pain during positioning more effectively than intravenous tramadol.
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Tipo de estudio
Inscripción (Actual)
Fase
- No aplica
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
Punjab Province
-
Lahore, Punjab Province, Pakistán, 54000
- Mayo Hospital, Lahore
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
- Adulto
Acepta Voluntarios Saludables
Descripción
Inclusion Criteria:
- Age 18-60 years
- Male or female patients
- American Society of Anesthesiologists physical status I or II
- Patients scheduled for femur fracture surgery under spinal anaesthesia
Exclusion Criteria:
- Multiple fractures
- Peripheral neuropathy
- Inability to communicate or provide reliable pain assessment
- History of allergy to local anaesthetic agents
Contraindication to spinal anaesthesia, including:
- Patient refusal
- Local infection at the injection site
- Coagulopathy
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Cuidados de apoyo
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Ninguno (etiqueta abierta)
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: Ultrasound-Guided Fascia Iliaca Compartment Block Group
Participants received an ultrasound-guided fascia iliaca compartment block through the infrainguinal approach using 30 mL of 1% lidocaine with adrenaline.
After 15 minutes, participants were positioned in the lateral decubitus position for spinal anaesthesia, and pain intensity was assessed using the visual analogue scale.
|
An ultrasound-guided infrainguinal fascia iliaca compartment block was administered with 30 mL of 1% lidocaine containing adrenaline.
|
|
Comparador activo: Intravenous Tramadol Group
Participants received intravenous tramadol at a dose of 1 mg/kg.
After 10 minutes, participants were positioned in the lateral decubitus position for spinal anaesthesia, and pain intensity was assessed using the visual analogue scale.
|
Tramadol was administered intravenously at a dose of 1 mg/kg before positioning for spinal anaesthesia.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Pain Intensity During Positioning for Spinal Anaesthesia
Periodo de tiempo: 10 minutes after intravenous tramadol or 15 minutes after ultrasound-guided fascia iliaca compartment block, immediately before spinal anaesthesia.
|
Pain intensity was assessed using a 0-10 visual analogue scale during placement of the participant in the lateral decubitus position before spinal anaesthesia.
A score of 0 represented no pain, while a score of 10 represented the worst possible pain.
Lower scores indicated better analgesic efficacy.
|
10 minutes after intravenous tramadol or 15 minutes after ultrasound-guided fascia iliaca compartment block, immediately before spinal anaesthesia.
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Change in Visual Analogue Scale Pain Score From Baseline to Positioning
Periodo de tiempo: 10 minutes after intravenous tramadol or 15 minutes after fascia iliaca compartment block.
|
The change in pain intensity was determined by comparing the visual analogue scale score recorded while the participant was lying on the operating table before the assigned intervention with the score recorded during lateral decubitus positioning.
A greater reduction in score indicated greater analgesic effectiveness.
|
10 minutes after intravenous tramadol or 15 minutes after fascia iliaca compartment block.
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Investigador principal: Adeel Ahmed, Mayo Hospital Lahore
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Actual)
Finalización del estudio (Actual)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
- Dolor
- Manifestaciones neurológicas
- Heridas y Lesiones
- Lesiones en las piernas
- Fracturas, Hueso
- Condiciones Patológicas, Signos y Síntomas
- Signos y síntomas
- Fracturas Femorales
- Dolor agudo
- Químicos orgánicos
- Lípidos
- Amina
- Alcoholes
- Ciclohexanoles
- Hexanols
- Alcoholes grasos
- Dimetilaminas
- Metilaminas
- Tramadol
Otros números de identificación del estudio
- Mayo8
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .